TGFB1 and systemic sclerosis: A plausible strategy to treat fibrosis in SSc is to block the autocrine TGF-β signaling in SSc fibroblasts and better understanding of its molecular mechanism is necessary to develop the treatment for this complicated disorder [1,7].